Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Charmacy Pharmaceutical CoHKSE:02289 76 Gross Margin % is 8.03% as of Dec. 2025, which is 27% above its 10-year median of 6.33. GuruFocus rates HKSE:02289 with a GF Score™ of 76/100 and a GF Value™ of HK$8.38 (Possible Value Trap). The stock has 3 warning signs investors should review. Among 118 Medical Distribution companies, Charmacy Pharmaceutical Co ranks worse than 83.05% on this metric.
HKSE:02289's Gross Margin % is ranked worse than 83.05% of 118
companies
in the Medical Distribution industry
Industry Median: 14.9
vs HKSE:02289: 7.75
Charmacy Pharmaceutical Co had a gross margin of 8.03% for the quarter that ended in Dec. 2025 => No sustainable competitive advantage
Charmacy Pharmaceutical Co (HKSE:02289) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Charmacy Pharmaceutical Co had a gross margin of 8.03% for the quarter that ended in Dec. 2025 => No sustainable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Charmacy Pharmaceutical Co Gross Margin % Related Terms
Charmacy Pharmaceutical Co Gross Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HKSE:02289 vs MCK, COR, CAH: Gross Margin % Comparison
For the Medical Distribution subindustry, Charmacy Pharmaceutical Co's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Charmacy Pharmaceutical Co Gross Margin % vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Charmacy Pharmaceutical Co's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Charmacy Pharmaceutical Co's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Charmacy Pharmaceutical Co (HKSE:02289) has a Gross Margin % of 8.03% as of Dec. 2025. Gross margin is the ratio of total gross profit to net sales. View historical data on Charmacy Pharmaceutical Co and its competitors. This is 27% above median its historical median of 6.33. Over the past decade, Charmacy Pharmaceutical Co's Gross Margin % has ranged from 4.95 to 7.75. According to the industry distribution chart, Charmacy Pharmaceutical Co ranks #98 out of 118 companies in the Medical Distribution industry, placing it in the top 83.1%.
Is Charmacy Pharmaceutical Co's Gross Margin % too high?
Charmacy Pharmaceutical Co's current Gross Margin % of 8.03% is 27% above median its 10-year median of 6.33. Over the past 10 years, this metric has ranged from a low of 4.95 to a high of 7.75. The Medical Distribution industry median Gross Margin % is 14.90. Charmacy Pharmaceutical Co's value of 8.03% is 46.1% below this industry median. Based on the distribution chart, Charmacy Pharmaceutical Co ranks #98 out of 118 companies in the Medical Distribution industry, which is in the bottom quartile relative to peers. Overall, Charmacy Pharmaceutical Co has a GF Score™ of 76/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Charmacy Pharmaceutical Co's Gross Margin % compare to MCK and COR?
According to the Medical Distribution industry distribution chart, Charmacy Pharmaceutical Co ranks #98 out of 118 companies for Gross Margin %. This places Charmacy Pharmaceutical Co in the lower half of its industry. The industry median Gross Margin % is 14.90. Charmacy Pharmaceutical Co's value of 8.03% is 46.1% below this benchmark. Historically, Charmacy Pharmaceutical Co's own Gross Margin % has ranged from 4.95 to 7.75 over the past decade. While the company's 10-year median is 6.33 vs. the industry median of 14.90, Charmacy Pharmaceutical Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Medical Distribution company?
The median Gross Margin % among Medical Distribution companies is 14.90, based on 118 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Charmacy Pharmaceutical Co's current Gross Margin % of 8.03% is 46.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Charmacy Pharmaceutical Co and its competitors. For the Medical Distribution industry, the median Gross Margin % is 14.90 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Charmacy Pharmaceutical Co's current Gross Margin % is 8.03%, which is 27% above median its own 10-year median of 6.33. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Charmacy Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Charmacy Pharmaceutical Co (HKSE:02289) is currently considered Possible Value Trap. The stock's GF Value™ is HK$8.38, compared to a current price of HK$5.50 — trading 34.4% below its estimated fair value. The current Gross Margin % is 8.03%, which is 27% above median its 10-year median of 6.33 and 46.1% below the Medical Distribution industry median of 14.90. Charmacy Pharmaceutical Co's overall GF Score™ is 76/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Charmacy Pharmaceutical Co (HKSE:02289), the current Gross Margin % is 8.03% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Charmacy Pharmaceutical Co (HKSE:02289) Overvalued in 2026?
Based on GuruFocus' analysis, Charmacy Pharmaceutical Co stock appears to be undervalued.
The current stock price of HK$5.50 is trading 34.4% below its estimated GF Value™ of HK$8.38.
GuruFocus considers Charmacy Pharmaceutical Co to be Possible Value Trap.
Key valuation signals for HKSE:02289:
Gross Margin %: 8.03% (27% above median its 10-year median of 6.33)
GF Value™: HK$8.38 vs. price of HK$5.50 (34.4% below fair value)
Industry Position: 46.1% below the Medical Distribution median (#98 of 118)
No single metric tells the full story. See the HKSE:02289 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Charmacy Pharmaceutical Co Ltd operates within the pharmaceutical distribution industry, with a primary focus on the distribution of pharmaceutical products. The principal business activities encompass the wholesale of pharmaceuticals and related services, along with road transportation and cargo warehousing. The company's distribution network covers Southern China and surrounding areas including Fujian province. All the group's operations are located in China.
76GF Score
Get the complete analysis for HKSE:02289
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:02289 has been successfully added to your 
